Kiniksa Pharmaceuticals International (KNSA) Gross Profit (2021 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Gross Profit came in at $220.0 million in Q2 2026, up 59.22% YoY from $138.2 million in Q2 2025, and up 13.73% on a QoQ basis from $193.5 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Gross Profit (2021 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 6 years of Gross Profit data on file, last reported at $220.0 million in Q2 2026.
- Quarterly Gross Profit rose 59.22% year-over-year to $220.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $755.3 million (up 66.05% YoY) and the FY2025 annual result came in at $599.9 million, up 65.57% from the prior year.
- Gross Profit grew to $220.0 million in Q2 2026, from $193.5 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $220.0 million in Q2 2026 to a low of -$155.0 million in Q4 2022.
- A 5-year average of $89.2 million and a median of $92.2 million in 2022 frame the typical range for Gross Profit.
- The widest YoY moves for Gross Profit: up 888.4% in 2022, down 1141.85% in 2022.
- Tracing KNSA's Gross Profit over 5 years: stood at -$155.0 million in 2022, then jumped by 147.62% to $73.8 million in 2023, then surged by 41.77% to $104.6 million in 2024, then soared by 73.15% to $181.2 million in 2025, then gained by 21.44% to $220.0 million in 2026.
- The last three Gross Profit figures came in at $220.0 million (Q2 2026), $193.5 million (Q1 2026), and $181.2 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 6.09 Bn | 5.56 Bn | 220.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 220.03 Mn |
| Jun 30, 2026 | 220.03 Mn |
| Mar 31, 2026 | 193.47 Mn |
| Mar 31, 2026 | 193.47 Mn |
| Dec 31, 2025 | 181.18 Mn |
| Dec 31, 2025 | 181.18 Mn |
| Sep 30, 2025 | 160.60 Mn |
| Sep 30, 2025 | 160.60 Mn |
| Jun 30, 2025 | 138.19 Mn |
| Jun 30, 2025 | 138.19 Mn |
| Mar 31, 2025 | 119.92 Mn |
| Mar 31, 2025 | 119.92 Mn |
| Dec 31, 2024 | 104.64 Mn |
| Dec 31, 2024 | 104.64 Mn |
| Sep 30, 2024 | 92.11 Mn |
| Sep 30, 2024 | 92.11 Mn |
| Jun 30, 2024 | 96.31 Mn |
| Jun 30, 2024 | 96.31 Mn |
| Mar 31, 2024 | 69.28 Mn |
| Mar 31, 2024 | 69.28 Mn |